SCHEMBL19635599

SCHEMBL19635599

C=C(C)c1ccccc1OC(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNK3 O14649 4/20 0.46
KCNK9 Q9NPC2 4/20 0.46
ALDH1A1 P00352 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
F2R P25116 1/20 0.41
ADRA2A P08913 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
HCRTR1 O43613 3/20 0.38
HCRTR2 O43614 3/20 0.38
HSD11B1 P28845 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
ANO1 Q5XXA6 1/20 0.38
HCN1 O60741 1/20 0.37
CLK1 P49759 1/20 0.37
MGLL Q99685 1/20 0.36
GAA P10253 1/20 0.36
RXRA P19793 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14127333 0.84 KCNK3 (0.48) KCNK3KCNK9ALDH1A1L3MBTL1CYP11B1
SCHEMBL2334101 0.82 ADRA2A (0.40) KCNK3KCNK9ALDH1A1ADRA2AADRA2B
SCHEMBL6722687 0.82 KCNK3 (0.43) KCNK3KCNK9ALDH1A1L3MBTL1CYP11B1
SCHEMBL12954616 0.81 KCNK3 (0.42) KCNK3KCNK9ALDH1A1L3MBTL1CYP11B1
SCHEMBL1286691 0.81 KCNK3 (0.56) KCNK3KCNK9ALDH1A1L3MBTL1CYP11B1
SCHEMBL20683623 0.80 F2R (0.44) KCNK3KCNK9ALDH1A1L3MBTL1CYP11B1
SCHEMBL23761699 0.78 ANO1 (0.44) KCNK3KCNK9ALDH1A1L3MBTL1CYP11B1
SCHEMBL20693195 0.78 KCNK3 (0.41) KCNK3KCNK9ALDH1A1L3MBTL1CYP11B1
SCHEMBL7188551 0.77 HTT (0.47) ALDH1A1ADRA2AADRA2BADRA2C
SCHEMBL2096726 0.77 KCNK3 (0.49) KCNK3KCNK9ALDH1A1L3MBTL1CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023215801-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF KUMQUAT BIOSCIENCES INC. (US) 2023-11-09 WO disclosed
WO-2019160813-A1 ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. (US) 2019-08-22 WO disclosed
WO-2017201150-A1 ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. (US) 2017-11-23 WO disclosed